IRIS- DESyne X2 in the IRIS-DES Registry

NCT03588481 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-01-02

No results posted yet for this study

Summary

This study evaluates effectiveness and safety of DESyne X2 in Routine Clinical Practice.

Conditions

  • Coronary Stenosis
  • Coronary Occlusion
  • Coronary Disease

Interventions

DEVICE

DESyne X2

Novolimus-eluting stent

Sponsors & Collaborators

  • CardioVascular Research Foundation, Korea

    collaborator OTHER
  • Seung-Jung Park

    lead OTHER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-28
Primary Completion
2026-12-31
Completion
2030-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03588481 on ClinicalTrials.gov